This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Miyarisan Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Takahisa Matsufuji: Innovator in Peptide Research
Introduction
Takahisa Matsufuji is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of solutions for health issues caused by certain bacteria.
Latest Patents
Matsufuji holds a patent for a peptide that inhibits the production of toxins by bacteria belonging to the genus Clostridium. This innovation aims to provide a means for preventing, treating, and controlling health damages, including food poisoning and infections. The cyclic peptide he developed contains the sequence Cys-Phe-Trp-Ala-His, which plays a crucial role in its effectiveness.
Career Highlights
Matsufuji is associated with Miyarisan Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in addressing public health concerns related to bacterial infections.
Collaborations
Matsufuji has collaborated with notable colleagues, including Tohru Shimizu and Kaori Ohtani, to further enhance the impact of his research.
Conclusion
Takahisa Matsufuji's innovative work in peptide research exemplifies the importance of scientific advancements in public health. His contributions are vital in the ongoing fight against bacterial infections and foodborne illnesses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile